Cargando…

Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model

BACKGROUND & AIMS: Sinusoidal obstruction syndrome (SOS) following oxaliplatin based chemotherapy can have a significant impact on post-operative outcome following resection of colorectal liver metastases. To date no relevant experimental models of oxaliplatin induced SOS have been described. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, S.M., Mann, J., Vasilaki, A., Mathers, J., Burt, A.D., Oakley, F., White, S.A., Mann, D.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710969/ https://www.ncbi.nlm.nih.gov/pubmed/23624001 http://dx.doi.org/10.1016/j.jhep.2013.04.014

Ejemplares similares

The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome
por: Robinson, S M, et al.
Publicado: (2013)

Response to 'Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome''
por: Robinson, S M, et al.
Publicado: (2016)

Comment on ‘The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome': Intraperitoneal FOLFOX does not consistently induce sinusoidal obstruction syndrome in C57BL/6 mice
por: Lentschener, Claude, et al.
Publicado: (2016)

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy
por: Seo, An Na, et al.
Publicado: (2014)

Treprostinil reduces endothelial damage in murine sinusoidal obstruction syndrome
por: Themanns, Madeleine, et al.
Publicado: (2018)

Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
por: Kobayashi, Shinichiro, et al.
Publicado: (2019)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Focal Sinusoidal Obstruction Syndrome Caused by Oxaliplatin-Induced Chemotherapy: A Case Report
por: Kawai, Takaharu, et al.
Publicado: (2016)

Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma
por: Sakumura, Miho, et al.
Publicado: (2017)

Cemiplimab-Associated Sinusoidal Obstruction Syndrome
por: Sarsour, Nadeen Y., et al.
Publicado: (2023)

Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer
por: Jeon, Hyeong-Joon, et al.
Publicado: (2011)

Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
por: Porcello Marrone, Luiz Carlos, et al.
Publicado: (2013)

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
por: Lacombe, Caroline, et al.
Publicado: (2023)

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
por: Lee, D-W, et al.
Publicado: (2013)

Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy
por: Poker, Ahmet, et al.
Publicado: (2022)

Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes
por: Yang, Xiao-Qian, et al.
Publicado: (2019)

Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013)

Bilateral optic disc oedema and associated optic neuropathy in the setting of FOLFOX chemotherapy
por: Turner, Liam D, et al.
Publicado: (2013)

Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer
por: Nguyen, T. Quang, et al.
Publicado: (2019)

Pulmonary Fibrosis Secondary to FOLFOX Chemotherapy: A Case Report
por: Soon, Wai Cheong, et al.
Publicado: (2014)

Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy
por: Okada, Shunji, et al.
Publicado: (2017)

Popliteal pseudoaneurysm after FOLFOX chemotherapy for metastatic colorectal cancer
por: Cosic, Luka, et al.
Publicado: (2019)

Hepatic Sinusoidal Obstruction Syndrome During Chemotherapy for Childhood Medulloblastoma: Report of a Case and Review of the Literature
por: Kotecha, Rishi S., et al.
Publicado: (2014)

Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
por: Shah, Urvi A., et al.
Publicado: (2018)

Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?
por: Kriege, Oliver, et al.
Publicado: (2023)

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
por: Kim, Chee Young, et al.
Publicado: (2015)

Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer
por: Faure, Marjorie, et al.
Publicado: (2017)

Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF
por: Xie, Honghu, et al.
Publicado: (2019)

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
por: Hiraide, Sakura, et al.
Publicado: (2019)

Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells
por: Tam, Shing-Yau, et al.
Publicado: (2023)

Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy
por: Patel, Jay, et al.
Publicado: (2023)

Mouse skeletal muscle adaptations to different durations of treadmill exercise after the cessation of FOLFOX chemotherapy
por: Halle, Jessica L., et al.
Publicado: (2023)

Gd-EOB-DTPA-enhanced MR findings in chemotherapy-induced sinusoidal obstruction syndrome in colorectal liver metastases
por: Ding, Ying, et al.
Publicado: (2020)

Histone Methyltransferase ASH1 Orchestrates Fibrogenic Gene Transcription During Myofibroblast Transdifferentiation
por: Perugorria, Maria Jesus, et al.
Publicado: (2012)

FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer
por: Guan, Yue, et al.
Publicado: (2020)

Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis
por: Stevenson, Heather L., et al.
Publicado: (2017)

Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
por: Park, Dawon, et al.
Publicado: (2018)

mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma
por: Matsunaga, Mototsugu, et al.
Publicado: (2016)

Busulfan: Sinusoidal obstruction syndrome with thrombotic microangiopathy: case report
Publicado: (2021)

Genetic Predictors for Sinusoidal Obstruction Syndrome—A Systematic Review
por: Waespe, Nicolas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d1s41ukcfss46bjstrafi0bvff